カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の肺炎球菌ワクチン接種市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Pneumococcal Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19552）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19552
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の肺炎球菌ワクチン接種市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

肺炎球菌ワクチン接種市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の肺炎球菌ワクチン接種の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

肺炎球菌ワクチン接種市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・PPSV 23、PCV 7/13、PCV 10

用途別セグメントは次のように区分されます。
・子供、大人

世界の肺炎球菌ワクチン接種市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、GSK、MSD、Sanofipasteur、CDIBP、WALVAX、Sinovac、Bio Kangtai

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、肺炎球菌ワクチン接種製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な肺炎球菌ワクチン接種メーカーの企業概要、2019年～2022年までの肺炎球菌ワクチン接種の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な肺炎球菌ワクチン接種メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別肺炎球菌ワクチン接種の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの肺炎球菌ワクチン接種の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での肺炎球菌ワクチン接種市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および肺炎球菌ワクチン接種の産業チェーンを掲載しています。
・第13、14、15章では、肺炎球菌ワクチン接種の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 肺炎球菌ワクチン接種の概要
- 種類別分析（2017年vs2021年vs2028年）：PPSV 23、PCV 7/13、PCV 10
- 用途別分析（2017年vs2021年vs2028年）：子供、大人
- 世界の肺炎球菌ワクチン接種市場規模・予測
- 世界の肺炎球菌ワクチン接種生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer、GSK、MSD、Sanofipasteur、CDIBP、WALVAX、Sinovac、Bio Kangtai
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：PPSV 23、PCV 7/13、PCV 10
・用途別分析2017年-2028年：子供、大人
・肺炎球菌ワクチン接種の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・肺炎球菌ワクチン接種のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・肺炎球菌ワクチン接種のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・肺炎球菌ワクチン接種の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・肺炎球菌ワクチン接種の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pneumococcal Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pneumococcal Vaccination market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Child accounting for % of the Pneumococcal Vaccination global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PPSV 23 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pneumococcal Vaccination include Pfizer, GSK, MSD, Sanofipasteur, and CDIBP, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pneumococcal Vaccination market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PPSV 23
PCV 7/13
PCV 10
Market segment by Application can be divided into
Child
Adult
The key market players for global Pneumococcal Vaccination market are listed below:
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
WALVAX
Sinovac
Bio Kangtai
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pneumococcal Vaccination product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccination, with price, sales, revenue and global market share of Pneumococcal Vaccination from 2019 to 2022.
Chapter 3, the Pneumococcal Vaccination competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccination breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pneumococcal Vaccination market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pneumococcal Vaccination.
Chapter 13, 14, and 15, to describe Pneumococcal Vaccination sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Pneumococcal Vaccination Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pneumococcal Vaccination Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 PPSV 23
1.2.3 PCV 7/13
1.2.4 PCV 10
1.3 Market Analysis by Application
1.3.1 Overview: Global Pneumococcal Vaccination Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Child
1.3.3 Adult
1.4 Global Pneumococcal Vaccination Market Size & Forecast
1.4.1 Global Pneumococcal Vaccination Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pneumococcal Vaccination Sales in Volume (2017-2028)
1.4.3 Global Pneumococcal Vaccination Price (2017-2028)
1.5 Global Pneumococcal Vaccination Production Capacity Analysis
1.5.1 Global Pneumococcal Vaccination Total Production Capacity (2017-2028)
1.5.2 Global Pneumococcal Vaccination Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pneumococcal Vaccination Market Drivers
1.6.2 Pneumococcal Vaccination Market Restraints
1.6.3 Pneumococcal Vaccination Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Pneumococcal Vaccination Product and Services
2.1.4 Pfizer Pneumococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Pneumococcal Vaccination Product and Services
2.2.4 GSK Pneumococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 MSD
2.3.1 MSD Details
2.3.2 MSD Major Business
2.3.3 MSD Pneumococcal Vaccination Product and Services
2.3.4 MSD Pneumococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanofipasteur
2.4.1 Sanofipasteur Details
2.4.2 Sanofipasteur Major Business
2.4.3 Sanofipasteur Pneumococcal Vaccination Product and Services
2.4.4 Sanofipasteur Pneumococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 CDIBP
2.5.1 CDIBP Details
2.5.2 CDIBP Major Business
2.5.3 CDIBP Pneumococcal Vaccination Product and Services
2.5.4 CDIBP Pneumococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 WALVAX
2.6.1 WALVAX Details
2.6.2 WALVAX Major Business
2.6.3 WALVAX Pneumococcal Vaccination Product and Services
2.6.4 WALVAX Pneumococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sinovac
2.7.1 Sinovac Details
2.7.2 Sinovac Major Business
2.7.3 Sinovac Pneumococcal Vaccination Product and Services
2.7.4 Sinovac Pneumococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bio Kangtai
2.8.1 Bio Kangtai Details
2.8.2 Bio Kangtai Major Business
2.8.3 Bio Kangtai Pneumococcal Vaccination Product and Services
2.8.4 Bio Kangtai Pneumococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pneumococcal Vaccination Breakdown Data by Manufacturer
3.1 Global Pneumococcal Vaccination Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pneumococcal Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pneumococcal Vaccination
3.4 Market Concentration Rate
3.4.1 Top 3 Pneumococcal Vaccination Manufacturer Market Share in 2021
3.4.2 Top 6 Pneumococcal Vaccination Manufacturer Market Share in 2021
3.5 Global Pneumococcal Vaccination Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pneumococcal Vaccination Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pneumococcal Vaccination Market Size by Region
4.1.1 Global Pneumococcal Vaccination Sales in Volume by Region (2017-2028)
4.1.2 Global Pneumococcal Vaccination Revenue by Region (2017-2028)
4.2 North America Pneumococcal Vaccination Revenue (2017-2028)
4.3 Europe Pneumococcal Vaccination Revenue (2017-2028)
4.4 Asia-Pacific Pneumococcal Vaccination Revenue (2017-2028)
4.5 South America Pneumococcal Vaccination Revenue (2017-2028)
4.6 Middle East and Africa Pneumococcal Vaccination Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pneumococcal Vaccination Sales in Volume by Type (2017-2028)
5.2 Global Pneumococcal Vaccination Revenue by Type (2017-2028)
5.3 Global Pneumococcal Vaccination Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pneumococcal Vaccination Sales in Volume by Application (2017-2028)
6.2 Global Pneumococcal Vaccination Revenue by Application (2017-2028)
6.3 Global Pneumococcal Vaccination Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pneumococcal Vaccination Sales by Type (2017-2028)
7.2 North America Pneumococcal Vaccination Sales by Application (2017-2028)
7.3 North America Pneumococcal Vaccination Market Size by Country
7.3.1 North America Pneumococcal Vaccination Sales in Volume by Country (2017-2028)
7.3.2 North America Pneumococcal Vaccination Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pneumococcal Vaccination Sales by Type (2017-2028)
8.2 Europe Pneumococcal Vaccination Sales by Application (2017-2028)
8.3 Europe Pneumococcal Vaccination Market Size by Country
8.3.1 Europe Pneumococcal Vaccination Sales in Volume by Country (2017-2028)
8.3.2 Europe Pneumococcal Vaccination Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pneumococcal Vaccination Sales by Type (2017-2028)
9.2 Asia-Pacific Pneumococcal Vaccination Sales by Application (2017-2028)
9.3 Asia-Pacific Pneumococcal Vaccination Market Size by Region
9.3.1 Asia-Pacific Pneumococcal Vaccination Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pneumococcal Vaccination Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pneumococcal Vaccination Sales by Type (2017-2028)
10.2 South America Pneumococcal Vaccination Sales by Application (2017-2028)
10.3 South America Pneumococcal Vaccination Market Size by Country
10.3.1 South America Pneumococcal Vaccination Sales in Volume by Country (2017-2028)
10.3.2 South America Pneumococcal Vaccination Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pneumococcal Vaccination Sales by Type (2017-2028)
11.2 Middle East & Africa Pneumococcal Vaccination Sales by Application (2017-2028)
11.3 Middle East & Africa Pneumococcal Vaccination Market Size by Country
11.3.1 Middle East & Africa Pneumococcal Vaccination Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pneumococcal Vaccination Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pneumococcal Vaccination and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pneumococcal Vaccination
12.3 Pneumococcal Vaccination Production Process
12.4 Pneumococcal Vaccination Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pneumococcal Vaccination Typical Distributors
13.3 Pneumococcal Vaccination Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Pneumococcal Vaccination Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pneumococcal Vaccination Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Pneumococcal Vaccination Product and Services
Table 6. Pfizer Pneumococcal Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Pneumococcal Vaccination Product and Services
Table 10. GSK Pneumococcal Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. MSD Basic Information, Manufacturing Base and Competitors
Table 12. MSD Major Business
Table 13. MSD Pneumococcal Vaccination Product and Services
Table 14. MSD Pneumococcal Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sanofipasteur Basic Information, Manufacturing Base and Competitors
Table 16. Sanofipasteur Major Business
Table 17. Sanofipasteur Pneumococcal Vaccination Product and Services
Table 18. Sanofipasteur Pneumococcal Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. CDIBP Basic Information, Manufacturing Base and Competitors
Table 20. CDIBP Major Business
Table 21. CDIBP Pneumococcal Vaccination Product and Services
Table 22. CDIBP Pneumococcal Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. WALVAX Basic Information, Manufacturing Base and Competitors
Table 24. WALVAX Major Business
Table 25. WALVAX Pneumococcal Vaccination Product and Services
Table 26. WALVAX Pneumococcal Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sinovac Basic Information, Manufacturing Base and Competitors
Table 28. Sinovac Major Business
Table 29. Sinovac Pneumococcal Vaccination Product and Services
Table 30. Sinovac Pneumococcal Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bio Kangtai Basic Information, Manufacturing Base and Competitors
Table 32. Bio Kangtai Major Business
Table 33. Bio Kangtai Pneumococcal Vaccination Product and Services
Table 34. Bio Kangtai Pneumococcal Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Pneumococcal Vaccination Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Units)
Table 36. Global Pneumococcal Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Pneumococcal Vaccination, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Pneumococcal Vaccination Production Capacity by Company, (Units): 2020 VS 2021
Table 39. Head Office and Pneumococcal Vaccination Production Site of Key Manufacturer
Table 40. Pneumococcal Vaccination New Entrant and Capacity Expansion Plans
Table 41. Pneumococcal Vaccination Mergers & Acquisitions in the Past Five Years
Table 42. Global Pneumococcal Vaccination Sales by Region (2017-2022) & (Units)
Table 43. Global Pneumococcal Vaccination Sales by Region (2023-2028) & (Units)
Table 44. Global Pneumococcal Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Pneumococcal Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Pneumococcal Vaccination Sales by Type (2017-2022) & (Units)
Table 47. Global Pneumococcal Vaccination Sales by Type (2023-2028) & (Units)
Table 48. Global Pneumococcal Vaccination Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Pneumococcal Vaccination Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Pneumococcal Vaccination Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Pneumococcal Vaccination Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Pneumococcal Vaccination Sales by Application (2017-2022) & (Units)
Table 53. Global Pneumococcal Vaccination Sales by Application (2023-2028) & (Units)
Table 54. Global Pneumococcal Vaccination Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Pneumococcal Vaccination Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Pneumococcal Vaccination Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Pneumococcal Vaccination Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Pneumococcal Vaccination Sales by Country (2017-2022) & (Units)
Table 59. North America Pneumococcal Vaccination Sales by Country (2023-2028) & (Units)
Table 60. North America Pneumococcal Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Pneumococcal Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Pneumococcal Vaccination Sales by Type (2017-2022) & (Units)
Table 63. North America Pneumococcal Vaccination Sales by Type (2023-2028) & (Units)
Table 64. North America Pneumococcal Vaccination Sales by Application (2017-2022) & (Units)
Table 65. North America Pneumococcal Vaccination Sales by Application (2023-2028) & (Units)
Table 66. Europe Pneumococcal Vaccination Sales by Country (2017-2022) & (Units)
Table 67. Europe Pneumococcal Vaccination Sales by Country (2023-2028) & (Units)
Table 68. Europe Pneumococcal Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Pneumococcal Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Pneumococcal Vaccination Sales by Type (2017-2022) & (Units)
Table 71. Europe Pneumococcal Vaccination Sales by Type (2023-2028) & (Units)
Table 72. Europe Pneumococcal Vaccination Sales by Application (2017-2022) & (Units)
Table 73. Europe Pneumococcal Vaccination Sales by Application (2023-2028) & (Units)
Table 74. Asia-Pacific Pneumococcal Vaccination Sales by Region (2017-2022) & (Units)
Table 75. Asia-Pacific Pneumococcal Vaccination Sales by Region (2023-2028) & (Units)
Table 76. Asia-Pacific Pneumococcal Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Pneumococcal Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Pneumococcal Vaccination Sales by Type (2017-2022) & (Units)
Table 79. Asia-Pacific Pneumococcal Vaccination Sales by Type (2023-2028) & (Units)
Table 80. Asia-Pacific Pneumococcal Vaccination Sales by Application (2017-2022) & (Units)
Table 81. Asia-Pacific Pneumococcal Vaccination Sales by Application (2023-2028) & (Units)
Table 82. South America Pneumococcal Vaccination Sales by Country (2017-2022) & (Units)
Table 83. South America Pneumococcal Vaccination Sales by Country (2023-2028) & (Units)
Table 84. South America Pneumococcal Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Pneumococcal Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Pneumococcal Vaccination Sales by Type (2017-2022) & (Units)
Table 87. South America Pneumococcal Vaccination Sales by Type (2023-2028) & (Units)
Table 88. South America Pneumococcal Vaccination Sales by Application (2017-2022) & (Units)
Table 89. South America Pneumococcal Vaccination Sales by Application (2023-2028) & (Units)
Table 90. Middle East & Africa Pneumococcal Vaccination Sales by Region (2017-2022) & (Units)
Table 91. Middle East & Africa Pneumococcal Vaccination Sales by Region (2023-2028) & (Units)
Table 92. Middle East & Africa Pneumococcal Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Pneumococcal Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Pneumococcal Vaccination Sales by Type (2017-2022) & (Units)
Table 95. Middle East & Africa Pneumococcal Vaccination Sales by Type (2023-2028) & (Units)
Table 96. Middle East & Africa Pneumococcal Vaccination Sales by Application (2017-2022) & (Units)
Table 97. Middle East & Africa Pneumococcal Vaccination Sales by Application (2023-2028) & (Units)
Table 98. Pneumococcal Vaccination Raw Material
Table 99. Key Manufacturers of Pneumococcal Vaccination Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Pneumococcal Vaccination Typical Distributors
Table 103. Pneumococcal Vaccination Typical Customers
List of Figures
Figure 1. Pneumococcal Vaccination Picture
Figure 2. Global Pneumococcal Vaccination Revenue Market Share by Type in 2021
Figure 3. PPSV 23
Figure 4. PCV 7/13
Figure 5. PCV 10
Figure 6. Global Pneumococcal Vaccination Revenue Market Share by Application in 2021
Figure 7. Child
Figure 8. Adult
Figure 9. Global Pneumococcal Vaccination Revenue, (USD Million) & (Units): 2017 & 2021 & 2028
Figure 10. Global Pneumococcal Vaccination Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Pneumococcal Vaccination Sales (2017-2028) & (Units)
Figure 12. Global Pneumococcal Vaccination Price (2017-2028) & (US$/Unit)
Figure 13. Global Pneumococcal Vaccination Production Capacity (2017-2028) & (Units)
Figure 14. Global Pneumococcal Vaccination Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Pneumococcal Vaccination Market Drivers
Figure 16. Pneumococcal Vaccination Market Restraints
Figure 17. Pneumococcal Vaccination Market Trends
Figure 18. Global Pneumococcal Vaccination Sales Market Share by Manufacturer in 2021
Figure 19. Global Pneumococcal Vaccination Revenue Market Share by Manufacturer in 2021
Figure 20. Pneumococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Pneumococcal Vaccination Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Pneumococcal Vaccination Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Pneumococcal Vaccination Sales Market Share by Region (2017-2028)
Figure 24. Global Pneumococcal Vaccination Revenue Market Share by Region (2017-2028)
Figure 25. North America Pneumococcal Vaccination Revenue (2017-2028) & (USD Million)
Figure 26. Europe Pneumococcal Vaccination Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Pneumococcal Vaccination Revenue (2017-2028) & (USD Million)
Figure 28. South America Pneumococcal Vaccination Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Pneumococcal Vaccination Revenue (2017-2028) & (USD Million)
Figure 30. Global Pneumococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 31. Global Pneumococcal Vaccination Revenue Market Share by Type (2017-2028)
Figure 32. Global Pneumococcal Vaccination Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Pneumococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 34. Global Pneumococcal Vaccination Revenue Market Share by Application (2017-2028)
Figure 35. Global Pneumococcal Vaccination Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Pneumococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 37. North America Pneumococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 38. North America Pneumococcal Vaccination Sales Market Share by Country (2017-2028)
Figure 39. North America Pneumococcal Vaccination Revenue Market Share by Country (2017-2028)
Figure 40. United States Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Pneumococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 44. Europe Pneumococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 45. Europe Pneumococcal Vaccination Sales Market Share by Country (2017-2028)
Figure 46. Europe Pneumococcal Vaccination Revenue Market Share by Country (2017-2028)
Figure 47. Germany Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Pneumococcal Vaccination Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Pneumococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Pneumococcal Vaccination Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Pneumococcal Vaccination Revenue Market Share by Region (2017-2028)
Figure 56. China Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Pneumococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 63. South America Pneumococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 64. South America Pneumococcal Vaccination Sales Market Share by Country (2017-2028)
Figure 65. South America Pneumococcal Vaccination Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Pneumococcal Vaccination Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Pneumococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Pneumococcal Vaccination in 2021
Figure 77. Manufacturing Process Analysis of Pneumococcal Vaccination
Figure 78. Pneumococcal Vaccination Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 肺炎球菌ワクチン接種のグローバル市場展望 2023年-2029年：PPSV 23、PCV 7/13、PCV 10
  • 10価肺炎球菌結合型ワクチンのグローバル市場展望 2023年-2029年：単回投与バイアル、プレフィルドシリンジ
  • 世界の肺炎球菌ワクチン多価市場2022年：市場規模予測（～2028年）
  • 世界の黄熱病用予防接種市場2022年：市場規模予測（～2028年）
  • 世界のインフルエンザ予防接種市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19552 )"世界の肺炎球菌ワクチン接種市場2022年：市場規模予測（～2028年）" (英文：Global Pneumococcal Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。